Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial

• Marte F. van der Bijl,
• Jenny van der Veen,
• Aernoud T.L. Fiolet,
• Eric Boersma,
• Jan H. Cornel,
• John W. Eikelboom,
• Stefan M. Nidorf,
• Peter L. Thompson,
• Jalina Jannink,
• Iris C.D. Westendorp,
• Arend Mosterd,
• Hester M. den den Ruijter,
• Jeanine E. Roeters van Lennep

Affiliations

Marte F. van der Bijl

Department of Internal Medicine Erasmus MC University Medical Center Rotterdam the Netherlands

Jenny van der Veen

Faculty of Medicine University Medical Center Utrecht the Netherlands

Aernoud T.L. Fiolet

Department of Cardiology University Medical Center Utrecht the Netherlands

Eric Boersma

Department of Cardiology Cardiovascular Institute, Thorax Center, Erasmus MC Rotterdam the Netherlands

Jan H. Cornel

Dutch Network for Cardiovascular Research (WCN) Utrecht the Netherlands

John W. Eikelboom

Department of Medicine McMaster University Hamilton Ontario Canada

Stefan M. Nidorf

GenesisCare Western Australia Perth Australia

Peter L. Thompson

Heart and Vascular Research Institute of Western Australia Perth Australia

Jalina Jannink

Department of Cardiology Meander Medical Centre Amersfoort the Netherlands

Iris C.D. Westendorp

Dutch Network for Cardiovascular Research (WCN) Utrecht the Netherlands

Arend Mosterd

Dutch Network for Cardiovascular Research (WCN) Utrecht the Netherlands

Hester M. den den Ruijter

Laboratory of Experimental Cardiology, University Medical Center Utrecht Utrecht University Utrecht the Netherlands

Jeanine E. Roeters van Lennep

Department of Internal Medicine Erasmus MC University Medical Center Rotterdam the Netherlands